{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-030865","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.924910+00:00","generated_at":"2026-05-31T10:24:18.720654+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oncocyte enters $7.5M ATM with Needham, terminates prior $50M BTIG ATM","bullets":["Enters Sales Agreement with Needham & Company for up to $7.5M of common stock at-the-market.","Terminates prior ATM agreement with BTIG, LLC dated June 11, 2021 for up to $50M.","Company may sell shares from time to time; Needham receives 3.0% commission on gross proceeds.","Net proceeds intended for working capital and general corporate purposes.","Placement shares registered under S-3 effective August 7, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-030865","json":"https://secwatch.observer/filing/0001493152-24-030865.json","markdown":"https://secwatch.observer/filing/0001493152-24-030865.md","text":"https://secwatch.observer/filing/0001493152-24-030865.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224030865/0001493152-24-030865-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224030865/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:24:18.720654+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}